AS2690168, identified by its CAS number 1393899-47-2, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds in this category typically exhibit unique functional groups that contribute to their reactivity and interaction with biological systems. AS2690168 may possess properties such as solubility in various solvents, stability under specific conditions, and a defined mechanism of action relevant to its intended use. Additionally, it may undergo various chemical reactions, including those typical of organic compounds, such as oxidation, reduction, or substitution. The compound's safety profile, including toxicity and environmental impact, would also be essential for its evaluation in pharmaceutical development. For precise details regarding its characteristics, including empirical formula, melting point, and specific applications, consulting specialized databases or scientific literature is recommended.

AS2690168

1393899-47-2: AS2690168, identified by its CAS number 1393899-47-2, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, physical properties, and biological activity may vary, compounds in this category typically exhibit unique functional groups that contribute to their reactivity and interaction with biological systems. AS2690168 may possess properties such as solubility in various solvents, stability under specific conditions, and a defined mechanism of action relevant to its intended use. Additionally, it may undergo various chemical reactions, including those typical of organic compounds, such as oxidation, reduction, or substitution. The compound's safety profile, including toxicity and environmental impact, would also be essential for its evaluation in pharmaceutical development. For precise details regarding its characteristics, including empirical formula, melting point, and specific applications, consulting specialized databases or scientific literature is recommended.

<p>AS2690168 hydrochloride is an orally active inhibitor of RANKL signaling that can suppress RANKL-induced osteoclastogenesis in RAW264 cells. AS2690168 is applicable in research related to pathological bone resorption.</p>

CAS 1393899-47-2

AS2690168

AS2690168 hydrochloride

Ref: TM-T204813